Arrhythmia Discrimination Algorithm Using Atrial Ventricular Rate Timing
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current implantable cardiac devices face challenges in accurately discriminating between ventricular tachyarrhythmia (VT) and supraventricular tachyarrhythmia (SVT), often leading to inappropriate therapies and suffering for patients due to overlapping heart rate ranges and the inability to distinguish between arrhythmias originating in the atria or ventricles.
Innovation Solution
A new arrhythmia discrimination algorithm that analyzes atrial and ventricular rates to determine which chamber's rate increased first, classifying arrhythmias as VT or SVT based on the chamber driving the arrhythmia, using validated interval decreases to identify the initiation chamber and differentiate between VT and SVT.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If implantable cardiac devices monitor ventricular rate to detect tachyarrhythmias, then they can identify rapid heart rates, but they cannot distinguish between VT and SVT due to overlapping rate ranges
Solution Approach 1:
The patent segments the analysis of tachyarrhythmia by dividing it into two independent components: ventricular rate monitoring and atrial rate monitoring. By separately analyzing the rates in each chamber and comparing their relationship, the device can determine whether the arrhythmia originates in the ventricle (VT) or atrium (SVT), thereby resolving the inability to distinguish between these conditions when using only ventricular rate monitoring.
2Reliability
If devices use ventricular rate thresholds to trigger therapy, then they respond to tachyarrhythmias, but they deliver inappropriate therapies for SVT misclassified as VT
Solution Approach 1:
The patent introduces atrial rate monitoring as an intermediary parameter between ventricular rate detection and therapy delivery decision. By measuring atrial rate and comparing it with ventricular rate, the device determines the origin of the arrhythmia before triggering therapy. This intermediary step prevents inappropriate therapy delivery for SVT while maintaining reliable therapy delivery for true VT.
3Measurement precision
If devices monitor both atrial and ventricular rates, then they can identify arrhythmia origin, but the device complexity increases
Solution Approach 1:
The patent utilizes the existing dual-chamber monitoring capability of implantable cardiac devices for a new purpose: arrhythmia origin determination. The same atrial and ventricular sensors and circuits used for basic rate monitoring are leveraged to provide sophisticated arrhythmia discrimination, avoiding the need for additional hardware and minimizing device complexity while achieving precise arrhythmia origin detection.
Data Source
AI summary
Validated atrial and/or ventricular interval decreases are used to discriminate between VT and SVT. Atrial and/or ventricular intervals are monitored in order to detect decreases in such intervals (which are indicative in increases in rate). The atrial intervals can be, e.g., AA intervals, and the ventricular intervals can be, e.g., VV intervals. A detected atrial and/or ventricular interval decrease can be a decrease that is greater than an interval decrease threshold. Detected atrial and/or ventricular interval decreases can be validated by examining atrial and/or ventricular intervals before and after a detected atrial and/or ventricular interval decrease. The use of the validated atrial and/or ventricular interval decreases to classify an arrhythmia as SVT or VT can be called arrhythmia initiation analysis, since it is believed to determine whether the initiation of the arrhythmia is in an atrium or a ventricle.